Anova Acquires Corlexia Clinical Services And Expands Leadership Team

first_img Twitter Local NewsBusiness LONDON & CHICAGO–(BUSINESS WIRE)–Feb 3, 2021– Anova Enterprises, Inc. (Anova), an organization dedicated to accelerating promising treatments to market with its transformative AnovaOS™ technology platform, and the industry’s first collaborative ‘learning system,’ and Corlexia Clinical Services, a contract research organization focused on complex clinical trials for patients with complex neurology and oncology diseases today announced the acquisition of Corlexia by Anova. The acquisition adds further depth and experience to the Anova leadership team, brings new clients to Anova, and expands Anova’s work in oncology and infectious diseases to neurological conditions. “Anova and Corlexia have worked together on several clinical trials throughout the COVID-19 pandemic,” said Jennifer Bonfrisco, CEO of Corlexia Clinical Services. “The more we worked together, the more we saw alignment of our ideas. We share the vision of building innovative ways to accelerate drug development. I created Corlexia to make complex clinical trials more accessible to Doctors and patients who need treatment options. Once I began working with Anova and using the AnovaOS™ platform, it was clear that it was a natural partnership. Corlexia’s network of Doctors and biotech clients have tremendous needs for the services Anova provides. We are excited to be a part of Anova’s team the and the many opportunities presented with the adoption of AnovaOS™. Chris Beardmore, CEO of Anova said, “The number of biopharmaceutical companies and sites using the AnovaOS TM platform continues to rise. It is vital for Anova to grow its experienced team of professionals to support these clients. The Corlexia team adds deep industry experience to Anova and adds a network of clinical sites conducting Alzheimers and IBD clinical trials to the AnovaOS™ platform. I am excited to have them join our work.” The acquisition of staff, studies and contractual relationships is expected to be completed in approximately 30 days. For further information on AnovaOS™ go to www.anovaevidence.com or contact: Anova Enterprises, Inc. Tel: +1 224 218 2408 (US) +44 203 871 2656 (UK) Email: [email protected] ENDS About Anova Anova Enterprises, Inc. (Anova) is accelerating clinical development with a technology platform (AnovaOS™) that brings participants in the clinical research process together to speed promising new treatments to market, at reduced cost and for a larger number of patients. We kickstart the development of new treatments through standardization and automation as no one else can do. www.anovaevidence.com Twitter feed at @anovaevidence Follow Anova at www.linkedin.com/company/anovaevidence View source version on businesswire.com:https://www.businesswire.com/news/home/20210203005040/en/ CONTACT: MEDIA CONTACT Martin Walsh [email protected] KEYWORD: ILLINOIS EUROPE UNITED STATES UNITED KINGDOM NORTH AMERICA INDUSTRY KEYWORD: BIOTECHNOLOGY TECHNOLOGY HEALTH PHILANTHROPY PUBLIC RELATIONS/INVESTOR RELATIONS PHARMACEUTICAL COMMUNICATIONS RESEARCH SOFTWARE FOUNDATION SCIENCE SOURCE: Anova Enterprises, Inc. Copyright Business Wire 2021. PUB: 02/03/2021 05:00 AM/DISC: 02/03/2021 05:00 AM http://www.businesswire.com/news/home/20210203005040/en Anova Acquires Corlexia Clinical Services And Expands Leadership Team Previous articleMajor Financial Organisations Deploy causaLens’ Pioneering Causal AI Platform to Discover Key Causal Insights and Generate More Profitable Trading StrategiesNext articleMyanmar’s military junta plans probe of last year’s election Digital AIM Web Support WhatsApp TAGS  Pinterestcenter_img Pinterest Twitter Facebook WhatsApp By Digital AIM Web Support – February 3, 2021 Facebooklast_img read more

Canadian Dressage Teams Announced For Wellington Nations Cups

first_img SIGN UP Horse Sport Enews More from News:MARS Bromont CCI Announces Requirements For US-Based RidersThe first set of requirements to allow American athletes and support teams to enter Canada for the June 2-6 competition have been released.Canadian Eventer Jessica Phoenix Reaches the 100 CCI4*-S MarkPhoenix achieved the milestone while riding Pavarotti at the inaugural 2021 CCI4*-S at the Land Rover Kentucky Three-Day Event.Tribunal Satisfied That Kocher Made Prolonged Use of Electric SpursAs well as horse abuse, the US rider is found to have brought the sport into disrepute and committed criminal acts under Swiss law.Washington International Horse Show Returns to TryonTIEC will again provide the venue for the WIHS Oct. 26-31 with a full schedule of hunter, jumper and equitation classes. Email* Subscribe to the Horse Sport newsletter and get an exclusive bonus digital edition!center_img We’ll send you our regular newsletter and include you in our monthly giveaways. PLUS, you’ll receive our exclusive Rider Fitness digital edition with 15 exercises for more effective riding. Equestrian Canada (EC) is pleased to announce the athletes who will represent the red and white in the CDIO 3* and CDIO-U25 Nations Cup, taking place March 16-21, 2021, during the 10th week of the Adequan Global Dressage Festival (AGDF) in Wellington, FL.Both veteran and up-and-coming Canadian athletes will compete against elite dressage athletes from around the world in a unique, team-based setting. The Canadian Dressage Team for the FEI Nations Cup CDIO 3* will be: The CDIO-U25 Nations Cup will also be featured at AGDF 10, providing athletes under the age of 25 with the opportunity to gain valuable experience in the team format. Team Canada will be composed of the following youth riders:Denielle Gallagher-Lagriffon, a Canadian residing in Loxahatchee, FL, will be Chef d’Équipe for both Canada’s senior and youth athletes.For more information on AGDF 10 and the Nations Cup, visit https://gdf.coth.com. Tags: Canadian Dressage Team, Adequan Global Dressage Festival, CDIO-U25 Nations Cup, FEI Nations Cup CDIO 3*, last_img read more